M Udvardy - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

M Udvardy

Showing results (91-100 of 97) with videos related to

Pageof 10

Sort By:

You have reached the last page of results.This site can display upto 97 results.

Orvosi Hetilap|November 12, 1998

[Hemostatic abnormalities in ischemic stroke]M Misz, L Oláh, J Kappelmayer, et al.

Orvosi Hetilap|May 9, 2001

[Molecular biology examination in chronic lymphocytic leukemia]B Telek, L Rejtó, G Mezei, et al.

Orvosi Hetilap|October 12, 2000

[Fluorescence in situ hybridization in the diagnosis and follow-up of chronic myelogenous leukemia]L Rejtó, M Balázs, R Adány, et al.

International Journal of Immunopathology and Pharmacology|June 11, 2011

Anti-TNF-alpha antibody (infliximab) therapy supports the recovery of eNOS and VEGFR2 protein expression in endothelial cellsI Altorjay, Z Veréb, Z Serfozo, et al.

Scandinavian Journal of Immunology|June 21, 2006

Clinical and immunoserological characteristics of mixed connective tissue disease associated with pulmonary arterial hypertensionJ Vegh, P Szodoray, J Kappelmayer, et al.

Leukemia & Lymphoma|August 26, 1998

Changes in oncogene expression implicated in evolution of chronic granulocytic leukemia from its chronic phase to accelerationZ Beck, A Bácsi, E Kovács, et al.

Orvosi Hetilap|August 10, 2000

[Detection of minimal residual diseases in B-cell tumors using PCR specific for the immunoglobulin heavy chain gene]A Matolcsy, Z Borbényi, J Demeter, et al.

Pageof 10

Search research articles

Showing results (91-100 of 97) with videos related to

Sort By:

Pageof 10

You have reached the last page of results.This site can display upto 97 results.

Orvosi Hetilap|November 12, 1998

[Hemostatic abnormalities in ischemic stroke]M Misz, L Oláh, J Kappelmayer, et al.

Orvosi Hetilap|May 9, 2001

[Molecular biology examination in chronic lymphocytic leukemia]B Telek, L Rejtó, G Mezei, et al.

Orvosi Hetilap|October 12, 2000

[Fluorescence in situ hybridization in the diagnosis and follow-up of chronic myelogenous leukemia]L Rejtó, M Balázs, R Adány, et al.

International Journal of Immunopathology and Pharmacology|June 11, 2011

Anti-TNF-alpha antibody (infliximab) therapy supports the recovery of eNOS and VEGFR2 protein expression in endothelial cellsI Altorjay, Z Veréb, Z Serfozo, et al.

Scandinavian Journal of Immunology|June 21, 2006

Clinical and immunoserological characteristics of mixed connective tissue disease associated with pulmonary arterial hypertensionJ Vegh, P Szodoray, J Kappelmayer, et al.

Leukemia & Lymphoma|August 26, 1998

Changes in oncogene expression implicated in evolution of chronic granulocytic leukemia from its chronic phase to accelerationZ Beck, A Bácsi, E Kovács, et al.

Orvosi Hetilap|August 10, 2000

[Detection of minimal residual diseases in B-cell tumors using PCR specific for the immunoglobulin heavy chain gene]A Matolcsy, Z Borbényi, J Demeter, et al.

Pageof 10